Skip to main content

Movers & Shakers: Nov 5, 2010

Premium

Denator this week announced it has appointed Marten Winge vice president for business development.

Previously, Winge was CEO of proteomics company Proxeon, which was purchased by Thermo Fisher Scientific in April.


Waters this week announced partnerships with several researchers as part of its new Centers of Innovation Program, which the company has launched in an effort to build collaborations with scientists working on UPLC-MS platforms.

The scientists include Jeremy Nicholson, professor and chair in biological chemistry, department of surgery and cancer, Imperial College; John Engen, associate professor of chemistry and chemical biology, Northeastern University; James Scrivens, department of biological sciences, University of Warwick; and Julie Leary, department of molecular and cellular biology, University of California, Davis.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.